NEW SIGNALING PATHWAY PROBES BASED ON NATURAL TOXINS
基于天然毒素的新信号通路探针
基本信息
- 批准号:6386897
- 负责人:
- 金额:$ 21.81万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-08-01 至 2002-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: There is a structurally diverse group of natural toxins,
includin okadaic acid, calyculin, microcystin LR, and tautomycin, that exert
their cytotoxic effects by inhibiting the serine-threonine protein
phosphatases PP1 and PP2A. This activity dramatically increases the
phosphorylation state of a variety of proteins within the cell, a process
that can have profound effects such as the disastrous disruption of
intracellular signal trafficking, the deposition of proteinacious plaque and
fibrils, and even unregulated cellular proliferation. The compounds
themselves are therefore not only acute hepatotoxins, but also tumor
promotors. Interestingly, despite the dissimilarities of the toxins
structures, these compounds are competitive inhibitors, namely, their
PP1/PP2A binding sites overlap.
Because as a group they inhibit PP1 and PP2A quite potently and specifically
relative to other known phosphatases such as PP2B (calcineurin), PP2C, and
the tyrosine phosphatases, several members of this group have become
important probes of intracellular signalling pathways. However, there are
problems of poor selectivity between the two phosphatases, which can result
in ambiguous results when attempts are being made to define the separate
roles of PP1 and PP2A in a given process. In particular, there is no known
membrane-permeable small molecule that inhibits PP1 with good selectivity.
A recently published X-ray crystal structure of a PP1-microcystin LR complex
provides a unique opportunity to explore binding interactions of all these
inhibitors with both PP1 and PP2A, and to develop new selective inhibitors
based on these natural products.
描述:有一组结构不同的天然毒素,
包括冈田酸、盏花素、微囊藻毒素LR和交托霉素,它们对
它们通过抑制丝氨酸-苏氨酸蛋白的细胞毒作用
磷酸酶PP1和PP2A。这一活动大大增加了
细胞内各种蛋白质的磷酸化状态,一个过程
这会产生深远的影响,比如灾难性的破坏
细胞内信号传递,蛋白斑块的沉积和
纤维,甚至不受控制的细胞增殖。这些化合物
因此,它们本身不仅是急性肝毒素,而且是肿瘤
推动者。有趣的是,尽管毒素不同
结构,这些化合物是竞争性抑制剂,即它们的
PP1/PP2A结合位点重叠。
因为作为一个群体,它们非常有效和特异地抑制PP1和PP2A
相对于其他已知的磷酸酶,如PP2B(钙调神经磷酸酶)、PP2C和
酪氨酸磷酸酶,这一组的几个成员已经成为
细胞内信号通路的重要探针。然而,有一些
两种磷酸酶之间选择性差的问题,这可能会导致
在尝试定义独立的
PP1和PP2A在特定过程中的作用。特别是,目前还没有已知的
膜透性小分子,具有良好的选择性抑制PP1。
最近发表的PP1-微囊藻毒素LR络合物的X射线晶体结构
提供了一个独特的机会来探索所有这些
同时含有PP1和PP2A的抑制剂,以及开发新的选择性抑制剂
基于这些天然产物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
A RICHARD CHAMBERLIN其他文献
A RICHARD CHAMBERLIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('A RICHARD CHAMBERLIN', 18)}}的其他基金
NEW SIGNALING PATHWAY PROBES BASED ON NATURAL TOXINS
基于天然毒素的新信号通路探针
- 批准号:
6181136 - 财政年份:1998
- 资助金额:
$ 21.81万 - 项目类别:
Control of PP1/PP2A Activity With Small Molecule Toxins
用小分子毒素控制 PP1/PP2A 活性
- 批准号:
6871233 - 财政年份:1998
- 资助金额:
$ 21.81万 - 项目类别:
NEW SIGNALING PATHWAY PROBES BASED ON NATURAL TOXINS
基于天然毒素的新信号通路探针
- 批准号:
2602736 - 财政年份:1998
- 资助金额:
$ 21.81万 - 项目类别:
Control of PP1/PP2A Activity With Small Molecule Toxins
用小分子毒素控制 PP1/PP2A 活性
- 批准号:
7218074 - 财政年份:1998
- 资助金额:
$ 21.81万 - 项目类别:
Control of PP1/PP2A Activity With Small Molecule Toxins
用小分子毒素控制 PP1/PP2A 活性
- 批准号:
7030245 - 财政年份:1998
- 资助金额:
$ 21.81万 - 项目类别:
NEW SIGNALING PATHWAY PROBES BASED ON NATURAL TOXINS
基于天然毒素的新信号通路探针
- 批准号:
6019426 - 财政年份:1998
- 资助金额:
$ 21.81万 - 项目类别:
Control of PP1/PP2A Activity With Small Molecule Toxins
用小分子毒素控制 PP1/PP2A 活性
- 批准号:
6777786 - 财政年份:1998
- 资助金额:
$ 21.81万 - 项目类别:
ENANTIOSELECTIVE SYNTHESIS OF MYO-INOSITOL DERIVATIVES
肌醇衍生物的对映选择性合成
- 批准号:
3305688 - 财政年份:1992
- 资助金额:
$ 21.81万 - 项目类别:
INTRODUCTION OF NON-NATURAL AMINO ACIDS INTO PROTEINS
将非天然氨基酸引入蛋白质中
- 批准号:
3301523 - 财政年份:1991
- 资助金额:
$ 21.81万 - 项目类别:
相似海外基金
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10448926 - 财政年份:2021
- 资助金额:
$ 21.81万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10491861 - 财政年份:2021
- 资助金额:
$ 21.81万 - 项目类别:
Collaboration in Regulatory Systems Strengthening and Standardization Activities to Increase Global Access to Safe and Effective Biological Products.
加强监管系统和标准化活动方面的合作,以增加全球获得安全有效的生物产品的机会。
- 批准号:
10675535 - 财政年份:2021
- 资助金额:
$ 21.81万 - 项目类别:
EPSRC Centre for Doctoral Training in Bioprocess Engineering Leadership (Complex Biological Products Manufacture)
EPSRC 生物过程工程领导力博士培训中心(复杂生物制品制造)
- 批准号:
EP/S021868/1 - 财政年份:2019
- 资助金额:
$ 21.81万 - 项目类别:
Training Grant
Exploring interactions and benefits of novel microbial biological products in blueberry propagation
探索新型微生物生物制品在蓝莓繁殖中的相互作用和益处
- 批准号:
529840-2018 - 财政年份:2018
- 资助金额:
$ 21.81万 - 项目类别:
Applied Research and Development Grants - Level 1
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403724 - 财政年份:2014
- 资助金额:
$ 21.81万 - 项目类别:
Standard Grant
GOALI: Collaborative Research: Industrial Implementation of Smart Biopolymers for Purification of Biological Products
目标:合作研究:用于生物制品纯化的智能生物聚合物的工业实施
- 批准号:
1403697 - 财政年份:2014
- 资助金额:
$ 21.81万 - 项目类别:
Standard Grant
Formulation and delivery approaches for water soluble biological products delivered through the skin focussing on L-Ascorbic Acid.
通过皮肤输送的水溶性生物产品的配方和输送方法,重点是 L-抗坏血酸。
- 批准号:
131690 - 财政年份:2014
- 资助金额:
$ 21.81万 - 项目类别:
Feasibility Studies
Formulation and stability of biological products for skin delivery focussing on Retinol.
以视黄醇为重点的皮肤输送生物制品的配方和稳定性。
- 批准号:
131338 - 财政年份:2013
- 资助金额:
$ 21.81万 - 项目类别:
Feasibility Studies
Demonstrate the effectiveness of antimicrobial protection of new types of Biological Products
展示新型生物制品抗菌保护的有效性
- 批准号:
429734-2011 - 财政年份:2012
- 资助金额:
$ 21.81万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)














{{item.name}}会员




